
Antheia's 2022 in Review: A Year of Value
Dear colleagues, friends, and followers: This year has been ripe with growth, major achievements, and opportunities to showcase who and...
Antheia's 2022 in Review: A Year of Value
Antheia CEO on How Biomanufacturing can De-Risk Pharmaceutical Production
Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing
Introducing Guerin Kob, Antheia’s VP of Supply Chain
Demystifying Synthetic Biology IV: Fermentation Bioprocess Development
Antheia Announces New Financing and Plans to Construct Pilot Plant Facility for Biomanufacturing
Demystifying Synthetic Biology III: The 21st Century Technologies Advancing Synthetic Biology
Introducing CPO Heidi Pucel
Demystifying Synthetic Biology II: Molecular Biology Advancements Enabling Synthetic Biology
Antheia Appoints Heidi Pucel as Chief People Officer
Demystifying Synthetic Biology: Building with the power of biology
Inspirational Women in STEM and Tech: Dr. Christina Smolke of Antheia On The 5 Leadership Lessons...
Seven Biopharma Trends to Watch in 2022
Introducing Zack McGahey, Antheia’s COO
Can Synthetic Biology Save Us? This Scientist Thinks So.
BioSpace Movers & Shakers, Nov. 19
Antheia Appoints Zack McGahey as Chief Operating Officer
Making Drugs From Yeast
Join the Movement to Build a Century-Defining Technology